EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-GuérinSamantha Cambier, Jorg R. Oddens, Richard Sylvester et al.|European Urology|2015Cited by 639
The MAPP research network: a novel study of urologic chronic pelvic pain syndromesJ. Quentin Clemens, Daniel J. Clauw, Emeran A. Mayer et al.|BMC Urology|2014Cited by 157